• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

biotech jobs

Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks
Biotech

After buyout, Gilead is laying off Arcellx staff on both coasts

With Gilead's $7.8 billion buyout of Arcellx complete, the California pharma is consolidating some of the workforce at the acquired company.
Fraiser Kansteiner May 5, 2026 3:12pm
Paraglider over Alps in autumn

Gilead abruptly parts ways with general counsel—Chutes & Ladders

Nov 21, 2025 8:30am
cardboard box with office belongings and a desk chair

Big pharma cuts and gene therapy woes: Inside Q3's layoffs

Oct 3, 2025 4:30pm
Graphic of a one dollar bill with nuts and bolts scattered across it

Bolt halves workforce again to find cash for cancer drug readout

Oct 2, 2025 6:45am
A series of dice with a bag on them illustrating cost cuts

Oric lays off 20% of workforce in focus on clinical-stage drugs

Aug 13, 2025 6:20am
Layoffs

Generation Bio jettisons 90% of employees, including R&D org

Aug 13, 2025 5:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings